Register

 

Functional Medicine - Chiropractic Doctor


Functional Medicine 206
Disease and the Mind Body Connection

3.0

$60.00 USD

Select for Purchase    Click here to Show Approved States/Countries

Hour 1:

  • Discuss PNI and its relationship to musculoskeletal conditions
  • Review the interaction of the Hippocampus-Pituitary-Adrenal axis with PNI and its effect on musculoskeletal conditions Discuss clinical approach to managing these syndromes

Hour 2:       

  • Explain what factors affect the baby boomer population
  • Establish Patient education and doctor patient relationship
  • Establish protocols to improve treatment outcomes

Hour 3:

  • Mind over matter- how the brain and neuropathways affect musculoskeletal conditions
  • Describe cellular structure connections
  • Evaluate patients with musculoskeletal conditions and consider the effect of the mind, body, cellular and neurological alterations manifesting of these conditions.

Michelle Binkowski, DC

AudioVisual Course

Functional Medicine 205
From outside-in, and Inside-out; The Environment-Intestine-Lung Axis

4.0

$80.00 USD

Select for Purchase    Click here to Show Approved States/Countries
  • Identify the risks and complications of long-term PPI (Proton Pump Inhibition) exposure, complicating factors increasing our risks and their correction, and “best practices” for prescribing this therapy.
  • Demonstrate a hiatal hernia correction technique with a Chiropractic Adjustment
  • Integrate and apply phytotherapy treatment of different causes of dysmotility (SIBO, SIFO, IBD, IBS, neuropathy) based upon identifying key colonocyte target receptors in both TH1 (autoimmune) VS TH2 (allergic) situations.
  • Identify and summarize Metabolic Inflammation, explain its’ triggers, resultant diseases and prescribe treatment for it.
  • Discuss inflammation in the Intestine-Lung axis, apply dietary and lifestyle preventative and corrective treatment.
  • Develop the use of therapeutic “biotics” for asthma, airway inflammation, and atopic disorders,
  • Associate GI and respiratory biodome imbalances with asthma and allergic disorders, and their relationship to allergic sensitization
  • Critique the interaction of the hygiene hypothesis and our “window of opportunity” to prevent asthma and allergic diseases
  • Apply home and office based environmental therapy to help limit daily allergic exposure, allergy and asthma reactions.

Grant Shapiro, DC

AudioVisual Course

Functional Medicine 204
The GI Microbiome and Autoimmunity-What Are the Connections and Do They Matter? - Case Studies

1.0

$20.00 USD

Select for Purchase    Click here to Show Approved States/Countries
  • Utilize clinical decision making related to the linkage and association between autoimmune disease prevalence and individual factors, including the GI microbiota composition, food immune reactions, stealth infections, molecular mimicry, and lack of early diverse antigen exposure, in practical clinical cases.
  • Interpret the available clinical laboratory testing related to autoimmune disease risk assessment, diagnosis, and clinical management, including qPCR molecular-based evaluation of the GI microbiota and predictive autoantibody tests in specific practical clinical case scenarios.
  • Apply the available evidence-based integrative and complementary therapeutic interventions for autoimmune disorders in specific practical clinical case scenarios.
  • Refer to other medical specialists and collaborative care opportunities in complex autoimmune disease clinical case scenarios.

David Brady, DC, ND, CCN, DACBN

AudioVisual Course

Functional Medicine 203
The GI Microbiome and Autoimmunity-What Are the Connections and Do They Matter? Part 3

1.0

$20.00 USD

Select for Purchase    Click here to Show Approved States/Countries
  • Identify the linkage and association between autoimmune disease prevalence and factors including lack of early diverse antigen exposure (i.e., the hygiene hypothesis).
  • Interpret the available predictive autoantibody test options for autoimmune disorders.
  • Learn to determine when to order the available clinical laboratory testing related to autoimmune disease risk assessment, diagnosis, and clinical management, including qPCR molecular-based evaluation of the GI microbiota, various food sensitivity assays, and predictive autoantibody tests.
  • Apply evidence-based integrative and complementary therapeutic interventions for improvement of the GI mucosal health and barrier function (i.e., leaky-gut syndrome) in autoimmune disorders. 

David Brady, DC, ND, CCN, DACBN

AudioVisual Course

Functional Medicine 202
The GI Microbiome and Autoimmunity-What Are the Connections and Do They Matter? Part 2

1.0

$20.00 USD

Select for Purchase    Click here to Show Approved States/Countries
  • Identify the differences in methodology and application between quantitative molecular testing (qPCR) versus next-generation sequencing of the GI microbiota in the support of clinical decision making.
  • Synthesize the available evidence-based integrative and complementary therapeutic GI antimicrobial interventions for treating GI dysbiosis, including in subjects with autoimmune disorders.
  • Explore the linkage and association between autoimmune disease prevalence and food immune reactions and sensitivities.
  • Apply the available evidence-based integrative and complementary therapeutic interventions using pro and pre-biotics for improving the GI ecology in subjects with autoimmune disorders.

David Brady, DC, ND, CCN, DACBN

AudioVisual Course

Functional Medicine 201 - 205
8.0

$160.00 USD

Select for Purchase    Click here to Show Approved States/Countries
  • This includes all content from Functional Medicine 201 thorugh 205. Please see educational objectives for those courses

Course Group includes all content from Functional Medicine courses numbered 201 thorugh 205

multiple

AudioVisual Course

Functional Medicine 201 - 204
The GI Microbiome and Autoimmunity-What Are the Connections and Do They Matter?

4.0

$80.00 USD

Select for Purchase    Click here to Show Approved States/Countries
Hour 1
  • Appreciate the current epidemiologic trends in autoimmune incidence, morbidity and mortality in the Western industrialized countries versus the under-developed world.
  • Acknowledge the importance placed in human biology on mucosal immunity and the massive amount of immune tissue and functional resources dedicated to GI mucosal immune surveillance.
  • Comprehend the linkage and association between autoimmune disease prevalence and factors including the GI microbiota composition, stealth infections, and molecular mimicry.
  • Apply clinical laboratory testing related to autoimmune disease risk assessment and diagnosis, including qPCR molecular-based evaluation of the GI microbiota.
Hour 2
  • Identify the differences in methodology and application between quantitative molecular testing (qPCR) versus next-generation sequencing of the GI microbiota in the support of clinical decision making.
  • Synthesize the available evidence-based integrative and complementary therapeutic GI antimicrobial interventions for treating GI dysbiosis, including in subjects with autoimmune disorders.
  • Explore the linkage and association between autoimmune disease prevalence and food immune reactions and sensitivities.
  • Apply the available evidence-based integrative and complementary therapeutic interventions using pro and pre-biotics for improving the GI ecology in subjects with autoimmune disorders.
Hour 3
  • Identify the linkage and association between autoimmune disease prevalence and factors including lack of early diverse antigen exposure (i.e., the hygiene hypothesis).
  • Interpret the available predictive autoantibody test options for autoimmune disorders.
  • Learn to determine when to order the available clinical laboratory testing related to autoimmune disease risk assessment, diagnosis, and clinical management, including qPCR molecular-based evaluation of the GI microbiota, various food sensitivity assays, and predictive autoantibody tests.
  • Apply evidence-based integrative and complementary therapeutic interventions for improvement of the GI mucosal health and barrier function (i.e., leaky-gut syndrome) in autoimmune disorders.
Hour 4
  • Utilize clinical decision making related to the linkage and association between autoimmune disease prevalence and individual factors, including the GI microbiota composition, food immune reactions, stealth infections, molecular mimicry, and lack of early diverse antigen exposure, in practical clinical cases.
  • Interpret the available clinical laboratory testing related to autoimmune disease risk assessment, diagnosis, and clinical management, including qPCR molecular-based evaluation of the GI microbiota and predictive autoantibody tests in specific practical clinical case scenarios.
  • Apply the available evidence-based integrative and complementary therapeutic interventions for autoimmune disorders in specific practical clinical case scenarios.
  • Refer to other medical specialists and collaborative care opportunities in complex autoimmune disease clinical case scenarios.

David Brady, DC, ND, CCN, DACBN

AudioVisual Course

Functional Medicine 201
The GI Microbiome and Autoimmunity-What Are the Connections and Do They Matter? Part 1

1.0

$20.00 USD

Select for Purchase    Click here to Show Approved States/Countries
  • Appreciate the current epidemiologic trends in autoimmune incidence, morbidity and mortality in the Western industrialized countries versus the under-developed world.
  • Acknowledge the importance placed in human biology on mucosal immunity and the massive amount of immune tissue and functional resources dedicated to GI mucosal immune surveillance.
  • Comprehend the linkage and association between autoimmune disease prevalence and factors including the GI microbiota composition, stealth infections, and molecular mimicry.
  • Apply clinical laboratory testing related to autoimmune disease risk assessment and diagnosis, including qPCR molecular-based evaluation of the GI microbiota.

David Brady, DC, ND, CCN, DACBN

AudioVisual Course